The global peptide synthesizers market was valued at US$ 312.2 Mn in 2018 and growing at a significant CAGR over the forecast period owing to increasing research activities by the universities and research institutes and growing number of pharmaceutical and biopharmaceutical companies coupled with the increasing demand for peptides due to their advantages over pharmaceutical drugs such as high specificity, high biological activity, ready availability, and low toxicity are expected to exhibit the growth of the market over the forecast period. Global peptide synthesizers market segmented on the basis product & services, by application, and sector
Request Sample Report:
[URL]https://www.precisionbusinessinsights.com/request-sample?product_id=36118[/URL]
North America leads the Global Peptide Synthesizers Market
PBI’s global peptide synthesizer’s market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America accounted for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to presence of prominent players and continuous support by the government and private sectors and development of novel technologies that can rapidly produce large quantities of customized peptides are expected to boost the growth of the market over the forecast period.
Global peptide synthesizers market further reveals that the key player’s increasingly adopting strategies such as acquisitions & mergers, strategic alliance and introduction of new technology in the market to enhance market revenue share and gaining significant geographic presence across the region. For instance, in 2014, Bachem the leading peptide manufacturer, and GlyTech Inc. the world-leading developer of glycosylated drugs, announced that they have entered into a co-promotion agreement for GlyTech's glycosylation technology. As part of the agreement, Bachem will leverage its sales and marketing resources to enhance GlyTech's partnering efforts and GlyTech will promote Bachem as the partner of choice for manufacture of its glycopeptides and glycoproteins. For instance, Activotec has launched its Activo-P11 Peptide Synthesizer during a recently held 29th European Peptide Symposium (EPS) in Gdansk, Poland.
Key player’s profiles in the report are CS Bio Company, Inc. (United States), Biotage AB (Sweden), Gyros Protein Technologies AB (Sweden), AAPPTec (United States), CEM Corporation (United States), Intavis Bioanalytical Instruments AG (Germany), Activotec (United Kingdom), and MultiSynTech GmbH (Germany).
Detailed Segmentation
By Application
o Vaccines
o Oncology
o Others
By Product
o Reagents
o Peptide Synthesizers
By End User
o Pharmaceutical and Biotechnology Companies
o CDMO/CRO
o Academic and Research Institutes
Geography
o North America
• U.S
• Canada
o Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• Rest of Asia-Pacific
o Rest of World
• Brazil
• South Africa
• Saudi Arabia
• Others
For More Information:
[URL]https://www.precisionbusinessinsights.com/market-reports/peptide-synthesizers-market[/URL]